MedTrace Logo

Hypo-fractionated Stereotactic Body Radiotherapy for Localized Prostate Cancer

NCT01059513 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 167

Last updated 2020-11-25

No results posted yet for this study

Summary

This is an observational study in which a questionnaire is used to obtain quality of life data after patients undergo a hypo-fractionated course of stereotactic body radiotherapy (SBRT) for the treatment of their prostate cancer. The SBRT itself is considered standard of care for these patients and as such, is not an official component of the study.

Conditions

Sponsors & Collaborators

  • Jonsson Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Christopher King, MD · University of California, Los Angeles

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-26
Primary Completion
2020-03-19
Completion
2020-03-19

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01059513 on ClinicalTrials.gov